Bumetanide for autism: more eye contact, less amygdala activation

We recently showed that constraining eye contact leads to exaggerated increase of amygdala activation in autism. Here, in a proof of concept pilot study, we demonstrate that administration of bumetanide (a NKCC1 chloride importer antagonist that restores GABAergic inhibition) normalizes the level of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjikhani, Nouchine, Åsberg Johnels, Jakob, Lassalle, Amandine, Zürcher, Nicole R., Hippolyte, Loyse, Gillberg, Christopher, Lemonnier, Eric, Ben-Ari, Yehezkel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827728/
https://www.ncbi.nlm.nih.gov/pubmed/29483603
http://dx.doi.org/10.1038/s41598-018-21958-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827728/
https://www.ncbi.nlm.nih.gov/pubmed/29483603
http://dx.doi.org/10.1038/s41598-018-21958-x

Ejemplares similares